Inflammatory Responses Recruiting Phase 1 / 2 Trials for Metformin (DB00331)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03772964Effects of Metformin in a Non-Diabetic Patient PopulationBasic Science